Prevalence of Enlarge Fetal Pancreas and Correlation with Gestational Diabetes Mellitus Prognosis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260108002

Enrollment

153

Registered

2026-01-08

Start date

2026-01-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal pancrease circumference at GA 18-22 weeks Fetal pancrease circumference, GDM

Interventions

Low risk pregnancy with no medical complication

Screening

Low risk pregnancy

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Singleton 2.correct gestational age 3.maternal age more than 18 years 4. undergo 75g oral glucose tolerance test

Exclusion criteria

Exclusion criteria: 1.Pregestational DM, FBS > 126 or HbA1C > 6.5% 2. abnormal placenta and umbilical cord 3.maternal medical disease 4. abnormal fetal anatomy

Design outcomes

Primary

Measure	Time frame
Prevalence of enlarge fetal pancrease circumference after intervention fetal pancrease circumferance (cm) from ultrasound	—

Secondary

Measure	Time frame
GDM diagnosis 10 weeks after intervention 75 gram OGTT	—

Countries

Thailand

Contacts

Public ContactThamonnat Prakham

Bhumibol Adulyadej hospital

thamonnat.prakham@gmail.com025347383

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026